Galenica AG/Fr. GALE
1D1W1MYTD1Y5YMAX
About Galenica AG
Galenica AG operates within the healthcare sector, focusing on pharmaceutical distribution, retail, and services in Switzerland. Its core business includes the distribution of medicines and health products, operating one of the largest pharmacy networks, and providing specialized healthcare logistics and digital services. Founded in 1927 and headquartered in Bern, Switzerland, Galenica leverages its extensive network and partnerships to maintain a strong presence in the Swiss market. The company is strategically positioned through its integration across the pharmaceutical supply chain, offering a comprehensive range of products and services to improve healthcare accessibility and efficiency.
- Ticker
- Fr. GALE
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 6,623
- Headquarters
- Bern, Switzerland
- Website
- www.galenica.com
Galenica AG Metrics
BasicAdvanced
CHF 4.2B
26.16
CHF 3.19
0.28
CHF 2.50
1.50%
Price and volume
Market cap
CHF 4.2B
Beta
0.28
52-week high
CHF 103.00
52-week low
CHF 80.30
Average daily volume
84K
Dividend rate
CHF 2.50
Financial strength
Current ratio
1.07
Quick ratio
0.642
Long term debt to equity
53.991
Total debt to equity
78.31
Dividend payout ratio (TTM)
78.72%
Interest coverage (TTM)
13.90%
Profitability
EBITDA (TTM)
255.693
Gross margin (TTM)
12.46%
Net profit margin (TTM)
3.71%
Operating margin (TTM)
4.77%
Effective tax rate (TTM)
17.18%
Revenue per employee (TTM)
CHF 650,000
Management effectiveness
Return on assets (TTM)
4.00%
Return on equity (TTM)
11.36%
Valuation
Price to earnings (TTM)
26.162
Price to revenue (TTM)
0.97
Price to book
2.94
Price to tangible book (TTM)
-232.58
Price to free cash flow (TTM)
21.767
Free cash flow yield (TTM)
4.59%
Free cash flow per share (TTM)
3.832
Dividend yield (TTM)
3.00%
Forward dividend yield
1.50%
Growth
Revenue change (TTM)
6.39%
Earnings per share change (TTM)
-17.39%
3-year revenue growth (CAGR)
5.09%
3-year earnings per share growth (CAGR)
-16.06%
3-year dividend per share growth (CAGR)
4.35%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.